Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 2 | 2022 | 201 | 0.940 |
Why?
|
| Th17 Cells | 1 | 2022 | 116 | 0.800 |
Why?
|
| Melanoma, Experimental | 2 | 2021 | 95 | 0.320 |
Why?
|
| Receptors, CCR7 | 1 | 2022 | 5 | 0.220 |
Why?
|
| Mucous Membrane | 1 | 2022 | 66 | 0.220 |
Why?
|
| Intestine, Small | 1 | 2022 | 89 | 0.210 |
Why?
|
| Chemokines | 1 | 2022 | 119 | 0.210 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 80 | 0.200 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2021 | 46 | 0.200 |
Why?
|
| Lymph Nodes | 1 | 2022 | 258 | 0.200 |
Why?
|
| Bacteria | 1 | 2022 | 193 | 0.200 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 79 | 0.200 |
Why?
|
| Interleukin-6 | 1 | 2022 | 330 | 0.190 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2020 | 4 | 0.190 |
Why?
|
| Phenylthiohydantoin | 1 | 2020 | 12 | 0.190 |
Why?
|
| Nitriles | 1 | 2020 | 68 | 0.190 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 69 | 0.180 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 107 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2021 | 212 | 0.180 |
Why?
|
| Benzamides | 1 | 2020 | 156 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 332 | 0.160 |
Why?
|
| Cytokines | 1 | 2022 | 866 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 756 | 0.150 |
Why?
|
| Lipopolysaccharides | 2 | 2010 | 455 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2015 | 18 | 0.140 |
Why?
|
| Glycolysis | 1 | 2015 | 79 | 0.130 |
Why?
|
| Glucose | 1 | 2015 | 307 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 265 | 0.120 |
Why?
|
| Apoptosis | 1 | 2020 | 1640 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 2550 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 41 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2010 | 62 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 219 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 397 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 69 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2007 | 114 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 114 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 199 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1034 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 1849 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2020 | 1692 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2020 | 1173 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1032 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2007 | 617 | 0.050 |
Why?
|
| Mice | 4 | 2020 | 8472 | 0.050 |
Why?
|
| Cross-Priming | 1 | 2021 | 10 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 76 | 0.050 |
Why?
|
| Animals | 5 | 2021 | 20877 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 118 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2020 | 132 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2020 | 2688 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 2790 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Receptors, OX40 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2015 | 75 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2015 | 133 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 258 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 241 | 0.030 |
Why?
|
| Superantigens | 1 | 2010 | 7 | 0.020 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2010 | 3 | 0.020 |
Why?
|
| Enterotoxins | 1 | 2010 | 40 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 167 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 86 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 100 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 1030 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 60 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 630 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2007 | 186 | 0.020 |
Why?
|
| Male | 1 | 2020 | 37281 | 0.010 |
Why?
|
| Female | 1 | 2020 | 38015 | 0.010 |
Why?
|